Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • baldeberre
    Junior Member
    • Aug 2009
    • 4

    #1

    SAM to GFF v0.2

    Hello All,

    I'm trying to convert the SAM mapping output to a GFF v0.2 file in order to use diBayes. I am having trouble figuring out how GFF v0.2 keeps track of indels. Information about mismatches can be presented in the 'g' and 'r' attributes, but I cannot figure out how does the "Corrected base space representation" represents indels (or if it's even supposed to).

    Any help/tips will be greatly appreciated.
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    Indels are represented by the CIGAR string. a 36-bp read with out indels would have CIGAR string "36M". If there is, say, an insertion of 5 bp after 10 bp, you have "10M5I21M".

    In case this is of use: My HTSeq Python framework has a convenient parser for SAM files that also helps you deal with the CIGAR strings.

    Comment

    • baldeberre
      Junior Member
      • Aug 2009
      • 4

      #3
      Simon, thanks for your input. I'm sorry I wasn't more clear. I can parse the SAM file without a problem, I'm just trying to figure out how to incorporate the information about indels contained in the CIGAR field of the SAM file into the "Corrected base space" of the GFF v0.2 format.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Working...